---
layout: post
title: "Fresenius Kabi USA, LLC, et al.; Withdrawal of Approval of Five Abbreviated New Drug Applications"
date: 2026-02-05 18:58:16 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-04153
original_published: 2022-02-28 00:00:00 +0000
significance: 8.00
---

# Fresenius Kabi USA, LLC, et al.; Withdrawal of Approval of Five Abbreviated New Drug Applications

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** February 28, 2022 00:00 UTC
**Document Number:** 2022-04153

## Summary

The Food and Drug Administration (FDA or Agency) is withdrawing approval of five abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/02/28/2022-04153/fresenius-kabi-usa-llc-et-al-withdrawal-of-approval-of-five-abbreviated-new-drug-applications)
- API: https://www.federalregister.gov/api/v1/documents/2022-04153

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
